|
|
News Breaks | | | | October 2, 2012 | | 06:31 EDT |  | DARA | Dara BioSciences regains compliance with NASDAQ
DARA BioSciences announced that on October 1, NASDAQ notified the company that it has regained compliance Rule 5550a2, which requires a minimum bid price of $1.00 for continued listing on the NASDAQ. The company further announced that in light of the company's regaining compliance with the Minimum Bid Price Rule, the special meeting of stockholders that was scheduled to take place on November 8 to consider a reverse stock split proposal has been cancelled. | |
|
News For DARA From The Last 14 Days Check below for free stories on DARA the last two weeks. |
|
|
| May 15, 2013 | | 16:51 EDT |  | DARA | Dara BioSciences reports Q1 EPS (11c), one estimate (7c)
Reports Q1 revenue $21.2K, may not compare to one estimate $510K. | |
|
|
|
|
|
|
